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Abstract
Background: Data on clinical characteristics and outcomes in regard to hip fracture (HF) type are controversial.
This study aimed to evaluate whether clinical and laboratory predictors of poorer outcomes differ by HF type.
Methods: Prospective evaluation of 761 consecutively admitted patients (mean age 82.3 ± 8.8 years; 74.9%
women) with low-trauma non-pathological HF. Clinical characteristics and short-term outcomes were recorded.
Haematological, renal, liver and thyroid status, C-reactive protein, cardiac troponin I, serum 25(OH) vitamin D, PTH,
leptin, adiponectin and resistin were determined.
Results: The cervical compared to the tronchanteric HF group was younger, have higher mean haemoglobin,
albumin, adiponectin and resistin and lower PTH levels (all P < 0.05). In-hospital mortality, length of hospital stay
(LOS), incidence of post-operative myocardial injury and need of institutionalisation were similar in both groups.
Multivariate analysis revealed as independent predictors for in-hospital death in patient with cervical HF male sex,
hyperparathyroidism and lower leptin levels, while in patients with trochanteric HF only hyperparathyroidism; for
post-operative myocardial injury dementia, smoking and renal impairment in the former group and coronary artery
disease (CAD), hyperparathyroidism and hypoleptinaemia in the latter; for LOS > 20 days CAD, and age > 75 years
and hyperparathyroidism, respectively. Need of institutionalisation was predicted by age > 75 years and dementia
in both groups and also by hypovitaminosis D in the cervical and by hyperparathyroidism in the trochanteric HF.
Conclusions: Clinical characteristics and incidence of poorer short-term outcomes in the two main HF types are
rather similar but risk factors for certain outcomes are site-specific reflecting differences in underlying mechanisms.
Keywords: Hip fracture type, Clinical characteristics, Predictors of outcomes
Introduction
In elderly people, hip fractures (HFs) are the commonest
cause for acute orthopaedic admissions [1] and the sec-
ond leading cause of hospitalisation and prolonged
length of stay (LOS) [2,3]. One of the important chal-
lenges in the management of HF is to identify patients
who are at high risk of poor outcome.
Although HFs dominantly are regarded as homoge-
nous, anatomical types–cervical and trochanteric–differ
in bone composition and parameters of proximal femur
geometry [4-11], as well as in epidemiological,
demographic and clinical characteristics [7,12-20]. It is
possible that shared biological mechanisms underlie the
site, accompanying comorbidities and risks of postopera-
tive complications and outcomes for each type of HF.
Apparently osteoporotic HFs and their outcomes are
attributable to complex interactions between multiple
factors, however, there may exist some common
mechanisms determining specific conditions linked to
the HF type. These may be indicators that would enable
clinicians to identify patients at risk and provide appro-
priate management.
Various factors have been reported to affect HF out-
comes, but the role of anatomic location and the poten-
tial implications for clinical practice have been
addressed in only few investigations with conflicting
* Correspondence: alex.fisher@act.gov.au
1Department of Geriatric Medicine, The Canberra Hospital, PO Box 11,
Woden, ACT 2606, Australia
Full list of author information is available at the end of the article
Fisher et al. Journal of Trauma Management & Outcomes 2012, 6:2
http://www.traumamanagement.org/content/6/1/2
© 2012 Fisher et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
results. Studies comparing cervical and trochanteric HFs
often evaluated only some clinical and/or laboratory
parameters or selected outcomes. The prevailing view
was that patients with trochanteric compared to cervical
HF have poorer outcomes [7,15,21,22]. However scienti-
fic reports on the association of HF type with pre-exist-
ing medical conditions, post-operative complications
[23-26], LOS [15,27-30], functional outcomes [27,31],
and mortality [7,15,17,22,27,32-38] are controversial.
In numerous studies adipocytokines, relatively novel
compounds produced by adipocytes, have been found to
link energy homeostasis with bone metabolism and to be
associated with chronic cardiovascular, metabolic, renal,
immunological and lung diseases, all of which are com-
mon in HF patients and may affect outcomes. However,
the physiological and pathophysiological roles of adipocy-
tokines in causation of various diseases and in predicting
mortality are still not fully understood and reports are
contradictory. Data regarding the role of the three most
studied adipocytokines, leptin, adiponectin and resistin,
in patients with HF are sparse [39-41] and their utility as
outcome predictors has not been evaluated.
We hypothesized that an integrated approach combin-
ing clinical, routine and novel laboratory variables by
HF type will improve understanding and prediction of
outcomes in these patients. Considering the potential
existence of common site-specific pathophysiological
mechanisms, it is important to find out whether the
interactions between numerous variables differ by HF
type and which of them are independent risk factors
that can be used in practice for outcome prediction.
Understanding the relationships between HF type,
comorbidities and postsurgical outcomes is important in
evaluating the role of pathophysiological mechanisms,
and may help in individualising prophylaxis, improving
prognosis, treatment planning and providing differen-
tially targeted interventions.
The aims of this study were to evaluate (1) whether
demographic, clinical haematologic and biochemical
parameters differ by HF type, (2) determine the useful-
ness of HF type as a predictor of short-term outcomes
and (3) investigate whether clinical and laboratory pre-
dictors of poorer outcomes differ by HF type.
Patients and methods
Study population
In this prospective cohort study, all patients aged ≥ 60
years who were admitted with a low-trauma non-patho-
logical hip fracture to the Canberra Hospital between
2000 and 2006 were included. Of 847 admitted patients
86 (10.1%) were excluded from the analysis because of
pathological HF due to primary or metastatic bone can-
cer, multiple myeloma, Paget’s disease or primary
hyperparathyroidism.
A detailed clinical history and full physical examination
was performed, previous case records reviewed and infor-
mation on demographic characteristics, pre-fracture resi-
dential status, use of walking aid, comorbidities,
medications, peri-operative complications, in hospital
management and short-term outcomes prospectively
recorded. The following 11 chronic conditions were
included in the analysis: hypertension, coronary artery
disease (CAD), previous myocardial infarction, atrial
fibrillation, history of stroke, transient ischaemic attack,
dementia, diabetes mellitus, Parkinson’s disease, chronic
obstructive pulmonary disease, and chronic kidney dis-
ease. The pre-operative general physical health status was
assessed according to the American Society of Anaesthe-
siologists (ASA) classification. All patients had operative
fracture treatment and followed a similar postoperative
protocol with mobilisation out of bed on day one.
The study was performed in accordance with the
Declaration of Helsinki, the protocol was approved by
the local Human Research Ethics Committee and all
patients or their carers gave informed consent.
Laboratory measurements
All patients underwent a standard battery of laboratory
tests prior to surgery usually within 12-24 hours after arri-
val at the Emergency Department. The routine tests
included full blood count, serum electrolytes, creatinine,
urea nitrogen, C-reactive protein (CRP), albumin and liver
function tests, thyroid stimulatory hormone (TSH), free
thyroxine (T4), vitamin B12, folic acid, iron, ferritin, trans-
ferrin, as well as cardiac troponin (cTnI), 25(OH) vitamin
D (25(OH)D) and intact PTH. Serum cTnI was deter-
mined by a two step chemilumenescent microparticle
immunoassay (Chemiflex, Abbott Labs, Mississauga,
Ontario, Canada). Serum 25 (OH)D was measured by
radioimmunoassay kit (Dia Sorin, Stillwater, MN, USA)
and intact PTH by two-site chemiluminescent enzyme-
linked immunoassay on DPC Immulite 2000 (Diagnostic
Products Corp, Los Angeles CA, USA). In these three
methods both the intra–and inter-assay coefficient of var-
iations (CVs) ranged from 2.1% to 12.7%. All other mea-
surements were performed by standard automated
laboratory methods. Serum calcium concentrations were
corrected for serum albumin. Glomerular filtration rate
was estimated (eGFR) [42]. All these analyses were per-
formed on the day of blood sampling. Serum cTnI and
CRP levels were also assessed within 24 hours post-opera-
tively and then after if elevated and/or clinically indicated.
For the analyses, hypovitaminosis D was defined as 25
(OH) D < 50 nmol/L and vitamin D deficiency as < 25
nmol/L. Secondary hyperparathyroidism was defined as
elevated serum PTH (> 6.8 pmol/L, the upper limit of
the laboratory reference range). Chronic kidney disease
was defined as an eGFR < 60 ml/min1.73 m2.
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In a subset of 284 patients serum concentrations of
leptin, adiponectin and resistin were measured in venous
blood collected after an overnight fast usually within 48
hours after arrival at the Emergency Department. The
plasma was centrifuged immediately and one serum
sample was frozen and stored at -70°C until measure-
ment. All samples were analysed at the same time with
commercially available kits of the same lot number
according to the manufacturer’s protocol, and blind to
any clinical information. Serum leptin was measured by
enzyme-linked immunosorbent assay (ELISA) kit
obtained from Diagnostic System Lab Inc (Webster, TX,
USA) and serum concentrators of resistin and adiponec-
tin were measured by human ELISA kits (B-bridge
International, Inc, Otsuka Pharmaceuticals, Japan). The
intra–and inter-assay CVs for these three variables were
4.6-8.9% and 2.3-10.9% respectively.
Outcome measures
These included: (1) postoperative myocardial injury as
defined by cardiac troponin I rise (> 0.06 μg/L), (2)
inflammatory response assessed by marked elevation of
CRP (> 100 mg/L), (3) length of hospital stay (LOS), (4)
being discharged to a permanent residential care facility
(RCF) for persons who were admitted from home and
(5) all-cause in-hospital mortality. We also determined
whether troponin rise and CRP elevation influenced the
three other outcomes.
Statistical analysis
Continuous variables were reported as means ± SD and
categorical variables as percentages. Comparisons
between groups were performed using analysis of var-
iance and Student’s t-test for continuous variables and
c-2 test for categorical variables. Pearson correlation
coefficient with log-transformed data (to achieve normal
distribution) was used to study the linear correlation
between variables. Univariate and multivariate (both lin-
ear and logistic) regression analyses were used to deter-
mine the odds ratio (OR) and 95% confidence intervals
(CI) for associations between HF-type (dependent vari-
able) and different clinical and laboratory variables; all
potential confounding variables with statistical signifi-
cance ≤ 0.15 on univariate analyses were included in the
final multivariate analyses. All reported P values are 2-
sided; P-values < 0.05 were considered statistically sig-
nificant. The data was analysed using the Stata software
version 10 (StataCorp, College Station, TX, USA).
Results
Hip fracture type and comorbidities
Among the 761 study patients, the mean age was 82.3 ±
8.8 years and 74.9% were women (Table 1). The patients
with trochanteric HF were slightly older than those with
cervical fracture, but this difference disappeared when
the age of females and males was analysed separately.
Among patients with trochanteric fracture males were
younger than females (p = 0.002). The most prevalent
comorbidity was hypertension (44.5%), followed by
dementia (29.1%), coronary artery disease (22.8%), cere-
brovascular disease (20.9%), type 2 diabetes mellitus
(16.3%), atrial fibrillation (13.2%), chronic obstructive
pulmonary disease (11.4%) and Parkinson’s disease
(4.4%). All these diseases were similarly common in
patients with cervical and trochanteric HF, except Par-
kinson’s which was more prevalent in the former group
(6.3% vs. 1.6%, p = 0.002). The proportion of patients
with two or more of the listed comorbidities among
both types of HF was also similar (39.1% and 47.2% for
cervical and trochantric HF, respectively, p = 0.215).
Near 1/3 of all patients were admitted from long-term
residential care facilities (RCF). The pre-fracture resi-
dence status, mobility (using a walking device) and life-
style habits (past and current smoking, use of alcohol)
did not differ between groups.
Comparison of laboratory parameters in patients with
cervical and trochanteric fracture
The mean values for a wide range of pre-operative hae-
matologic variables as well as for biochemical para-
meters of liver, renal and thyroid functions in patients
with two types of HF were similar (Table 2). Among
routine parameters only mean haemoglobin and albu-
min levels differed significantly, both being slightly
lower in patients with trochanteric than cervical HF.
Although in the former group the prevalence of anaemia
(haemoglobin < 120 g/L, 43.0% vs. 33.6%, p = 0.097) and
hypoalbuminaemia (< 33 g/L, 28.2% vs. 27.0%, p =
0.819) was slightly higher, the difference was not signifi-
cant. This was also true for the prevalence of chronic
kidney disease on admission (GFR < 60 ml/min 1.73 m2,
43.7% vs. 42.8%, p = 0.876).
The prevalence of hypovitaminosis D (25(OH) D < 50
nmol/L, 77.8% in cervical vs. 82.1% in trochanteric HF,
p = 0.370) and vitamin D deficiency (25(OH) D < 25
nmol/L, 34% vs. 24.6%, respectively, p = 0.086) did not
differ significantly between groups. Although 25(OH) D
concentrations were similarly low in both groups, sec-
ondary hyperparathyroidism (PTH > 6.8 pmol/L) was
present in 30.2% of patients with cervical and in 41.3%
with trochanteric HF (p = 0.033), and the mean PTH
value was significantly higher in the latter group (p =
0.001). Among patients with cervical HF and 25(OH) D
< 25 nmol/L, blunted PTH response (PTH within nor-
mal limits) was more common than in subjects with tro-
chanteric HF (61.2% vs. 43.8%, p = 0.029). Compared to
patients with cervical HF those with trochanteric frac-
ture had significantly lower mean serum levels of
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adiponectin and resistin and a higher leptin: resistin
ratio (1.7 vs. 1.1; p = 0.024). After adjustment for age
and sex the prevalence of higher serum adiponectin (>
17.1 ng/ml, median level) and resistin (> 16.3 ng/ml,
median level) concentrations in patients with cervical
HF was respectively 1.7 (OR = 1.74; 95% CI 1.06-2.86; p
= 0.029) and 1.9 (OR = 1.95; 95% CI 1.18-3.20; p =
0.007) fold higher than in patients with trochanteric
fracture.
Correlations by hip fracture type
These analyses revealed similarities and differences asso-
ciated with the HF type (Table 3). In both cervical and
trochanteric HF groups, age correlated positively with
PTH, cTnI and adiponectin, and negatively with eGFR,
haemoglobin correlated positively with eGFR and eGFR
correlated negatively with cTnI. In both groups an
inverse correlation between PTH and serum calcium
(corrected for albumin) as well as eGFR was also pre-
sent. 25(OH) D was not correlated with any of the vari-
ables. Other correlations were site-specific.
In patients with cervical HF, PTH correlated positively
with leptin and LOS, and albumin correlated with
eGFR. In patients with trochanteric HF, PTH correlated
positively with serum phosphate, adiponectin, resistin
and cTnI. Only in this group age correlated negatively
with leptin and positively with resistin; leptin correlated
positively with haemoglobin and negatively with adipo-
nectin and adiponectin correlated negatively with CRP;
resistin correlated positively with calcium and negatively
with eGFR and cTnI correlated negatively with
haemoglobin.
Table 1 Demographic and clinical characteristics and short-term outcomes in older patients with hip fracture by
anatomical site
Characteristics Total group
(n = 761)
Cervical HF
(n = 444)
Trochanteric
(n = 317)
P value
Age, years (mean ± SD) 82.3 ± 8.8 81.7 ± 8.2 83.1 ± 9.5 0.034
Age, females, years (mean ± SD) 82.6 ± 7.7 81.9 ± 7.8 83.1 ± 7.5 0.143
Age, males, years (mean ± SD) 80.6 ± 8.3 81.5 ± 7.3 79.8 ± 9.1 0.359
Females, % 74.9 74.8 75.1 0.489
Admitted from long-term RCF, % 30.3 31.3 29.3 0.705
ASA score ≥ 3, % 72.9 71.1 75.0 0.497
Coronary artery disease, % 22.8 23.8 21.3 0.435
Previous myocardial infarction, % 5.3 4.8 6.1 0.431
Hypertension, % 44.5 44.8 44.1 0.855
Atrial fibrillation, % 13.2 11.6 15.4 0.136
History of stroke, % 13.5 14.4 12.5 0.643
TIA, % 7.4 7.5 7.3 0.942
Dementia, % 29.1 28.5 29.9 0.670
Diabetes mellitus, % 16.3 17.1 15.5 0.709
COPD, % 11.4 10.2 13.1 0.220
Parkinson’s disease, % 4.4 6.3 1.6 0.002
Current smoker, % 5.4 5.2 5.7 0.752
Ex-smoker, % 9.5 10.6 8.0 0.218
*Alcohol over user, % 5.5 6.1 4.8 0.431
User of walking device, % 34.5 33.5 36.0 0.476
CRP, mg/L 130.6 ± 82.1 134.9 ± 90.7 126.0 ± 71.7 0.356
Post-operative Tnl > 0.06 μg/L, % 27.0 29.5 24.5 0.343
CRP > 100 mg/L % 61.2 61.6 60.7 0.878
LOS , days (mean ± SD) 22.4 ± 23.4 20.9 ± 22.6 24.3 ± 24.4 0.054
LOS ≥ 20 days, % 31.7 28.3 35.3 0.206
New discharges to long-term RCF, % 49.0 48.1 490 0.787
In-hospital death, % 4.9 5.3 4.2 0.676
*Three or more times per week.
RCF, residential care facility; TIA, transient ischaemic attack; ASA, American Society of Anaesthesiologists; COPD, chronic obstructive pulmonary disease; LOS,
length of stay; cTnI, cardiac troponin I; CRP, C-reactive protein; RCF, residential care facility.
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Hip fracture type and short-term outcomes
Short-term outcomes such as peri-operative myocar-
dial injury (assessed by cardiac troponin I rise), length
of hospital stay (LOS), being discharged to RCF as
well as in-hospital death did not show significant dif-
ference between patients with cervical and trochan-
teric HF (Table 1). The mean values of the highest
post-operative CRP concentrations and the incidence
and degree of its elevation also did not differ between
groups.
Hip fracture type and predictors of outcomes
Only a limited number of the 17 clinical and 35 labora-
tory parameters tested were found associated with risk
of poorer outcomes. On univariate analyses these
included age, sex, CAD, dementia, ASA ≥ 3, smoking,
eGFR, haemoglobin, 25(OH)D, PTH, leptin, adiponectin
and resistin levels, but with different impact on specific
outcomes by HF type.
Multivariate analyses which included only clinical
characteristics (age, sex, residency, above mentioned co-
Table 2 Haematologic and biochemical parameters in older patients with hip fracture by anatomical site
Characteristics Total group
(n = 761)
Cervical HF
(n = 444)
Trochanteric HF
(n = 317)
P value
Erythrocyte count, x1012/L 4.1 ± 0.60 4.1 ± 0.61 4.0 ± 0.59 0.084
Haemoglobin, g/L 125.5 ± 16.6 128.2 ± 16.2 121.8 ± 16.5 0.000
Leukocyte count, x109/L 10.6 ± 4.2 10.5 ± 4.1 10.8 ± 4.4 0.430
Lymphocytes count, x109/L 1.29 ± 1.22 1.26 ± 1.47 1.32 ± 0.88 0.632
MCV, fl 90.4 ± 8.16 90.3 ± 6.31 90.5 ± 9.78 0.776
MCH, pg/cell 30.7 ± 2.44 30.5 ± 2.56 30.9 ± 2.29 0.198
MCHC, g/L 340.3 ± 34.2 341.2 ± 46.6 339.3 ± 10.19 0.642
RDW, % 15.2 ± 8.7 15.5 ± 12.0 14.8 ± 1.90 0.518
Iron, μmol/L 5.2 ± 4.33 4.8 ± 3.65 5.7 ± 4.92 0.085
Transferrin, g/L 1.7 ± 0.48 1.7 ± 0.52 1.7 ± 0.42 0.324
Transferrin saturation, % 11.6 ± 8.6 10.7 ± 7.9 12.5 ± 9.3 0.095
Ferritin, μg/L 298.8 ± 273.1 290.4 ± 225.4 307.9 ± 317.0 0.606
Vitamin B12, pmol/L 395.9 ± 271.4 410.6 ± 276.9 380.1 ± 265.4 0.3601
Folic acid (serum), nmol/L 26.1 ± 15.6 26.7 ± 16.1 25.4 ± 15.0 0.505
Albumin, g/L 35.3 ± 6.4 36.0 ± 6.5 34.5 ± 6.2 0.002
Bilirubin, μmol/L 12.4 ± 7.4 12.9 ± 7.8 11.8 ± 6.9 0.214
ALT, U/L 23.0 ± 42.6 29.9 ± 53.9 21.6 ± 25.5 0.581
ALP, U/L 105.4 ± 80.1 104.3 ± 78.6 106.6 ± 82.0 0.813
GGT, U/L 54.1 ± 95.6 54.6 ± 87.3 53.7 ± 104.0 0.936
Urea, mmol/L 8.8 ± 9.1 8.6 ± 10.1 9.0 ± 7.5 0.531
Creatinine, μmol/L 92.9 ± 49.9 91.0 ± 40.3 95.6 ± 60.8 0.217
eGFR, ml/min ·1·73 m2 65.1 ± 23.7 65.8 ± 23.1 64.3 ± 24.4 0.600
TSH, mIU/L 1.5 ± 2.17 1.7 ± 2.76 1.4 ± 27 0.246
T4, pmol/L 15.9 ± 3.54 16.1 ± 3.64 15.7 ± 3.43 0.336
Serum calcium*(mmol/L) 2.28 ± 0.13 2.28 ± 0.13 2.27 ± 0.13 0.661
Serum phosphate(mmol/L) 0.94 ± 0.48 0.92 ± 0.29 0.97 ± 0.62 0.447
Serum magnesium(mmol/L) 0.78 ± 0.13 0.76 ± 0.13 0.79 ± 0.12 0.059
25(OH)vitamin D(nmol/L) 37.3 ± 18.0 36.9 ± 18.7 37.6 ± 17.4 0.729
PTH(pmol/L) 6.9 ± 5.6 5.9 ± 3.6 8.0 ± 6.9 0.001
Leptin (ng/ml) 18.4 ± 23.17 18.1 ± 21.73 18.8 ± 24.67 0.797
Adiponectin (ng/ml) 17.5 ± 7.35 18.5 ± 7.29 16.3 ± 7.28 0.019
Resistin (ng/ml) 18.7 ± 10.46 20.1 ± 10.49 16.9 ± 10.19 0.014
Values are mean ± SD.
MCV, mean corpuscular volume; MCHC, mean corpuscular haemoglobin concentration; RDW, red-cell distribution; ALT, alanine aminotransferase; ALP, alkaline
phosphatase; GGT, gamma-glutamyltransferase; eGFR, estimated glomerular filtration rate; TSH, thyroid-stimulating hormone; T4, total thyroxine; CRP, C-reactive
protein (highest post-operative levels). Leptin, adiponectin and resistin were measured in 284 patients (147 with cervical and 137 with trochanteric HF).
All variables reflect data on admission (pre-operatively).
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morbidities, ASA score ≥ 3, and smoking) on admission
revealed the following significant independent predictors
for specific outcomes. Post-operative myocardial injury
(cTnI > 0.06 μg/L): in patients with cervical HF age (OR
= 1.13; 95% CI 1.05-1.23; p = 0.001) and current smok-
ing (OR = 11.2; 95% CI 1.4-88.3; p = 0.022); in patients
with trochanteric HF age (OR = 1.13; 95% CI 1.03-1.24;
p = 0.009) and history of CAD (OR = 6.4; 95% CI 1.7-
24.2; p = 0.007). Post-operative marked inflammatory
response (CRP > 100 mg/L): age (OR = 0.92; 95% CI
0.86-0.98; p = 0.013) in patients with trochanteric HF.
Prolonged LOS (≥ 20 days): in cervical HF patients CAD
(OR = 4.3; 95% CI 1.5-11.9; p = 0.005) and in trochan-
teric HF patients age (OR = 1.08; 95% CI 1.02-1.15; p =
0.014). Need of institutionalization: in cervical HF age
(OR = 1.17; 95%CI 1.05-1.29; p = 0.003), ASA ≥ 3 (OR
= 5.0; 95% CI 1.2-21.6; p = 0.031) and dementia (OR =
80.2; 95% CI 5.3-321.1; p = 0.002), in trochanteric HF
age (OR = 1.20; 95% CI 1.07-1.35; p = 0.002) and
dementia (OR = 6.0; 95%CI 1.2-30.2; p = 0.031). All
patients who died in the hospitals had ASA ≥ 3 and
were smokers. None of the other clinical variables in
multivariate models were independent predictors of in-
hospital death.
Further confirmation of important differences between
cervical and trochanteric HF patients in respect to fac-
tors that influence outcomes has been noted from the
analyses of laboratory parameters. In the multivariate
models which included 25(OH) D, PTH, haemoglobin,
albumin, calcium, phosphate, magnesium, eGFR, leptin,
adiponectin and resistin as continuous independent vari-
ables, the following factors emerged as significant pre-
dictors of poorer outcomes. Post-operative myocardial
injury: in patients with cervical HF eGFR (OR = 0.97;
95%CI 0.94-0.99; p = 0.007) and in patients with tro-
chanteric HF, PTH (OR = 1.11; 95% CI 1.01-1.23; p =
0.038), 25(OH) D (OR = 0.96; 95% CI 0.92-0.99; p =
0.034), eGFR (OR = 0.95; 95% CI 0.92-0.99; p = 0.007).
Inflammatory response: 25(OH)D (OR = 0.97; 95%CI
0.95-0.99; p = 0.017) in patients with cervical HF. Pro-
longed LOS: PTH (OR = 1.13; 95%CI 1.01-1.27; p =
0.037) in patients with cervical HF. Need of institutiona-
lization: leptin (OR = 0.96; 95% CI 0.92-0.99; p = 0.033)
in patients with trochanteric HF. In-hospital death: in
patients with cervical HF PTH (OR = 1.40; 95% CI 1.04-
1.88; p = 0.027) and leptin (OR = 0.81; 95% CI 0.66-
0.99; p = 0.040) and PTH (OR = 1.34; 95% CI 1.03-1.73;
p = 0.027) in patients with trochanteric HF.
Finally, logistic regression analyses which included
both clinical and laboratory parameters as categorical
variables (all with p ≤ 0.15 in univariate analyses) were
performed to identify independent risk or protection
factors for each study short-term outcome (as the
dependant variable). For prolonged LOS, need of a per-
manent RCF and in-hospital mortality postoperative tro-
ponin rise and marked CRP elevation were also included
in the models. Table 4 shows that independent predic-
tors of specific outcomes differ significantly by HF type.
Independent predictors of postoperative myocardial
injury in patients with cervical HF were dementia, renal
failure and current smoking. In subjects with trochan-
teric HF this complication was predicted by a history of
CAD, secondary hyperparathyroidism and lower leptin
levels. Only in trochanateric HF was anaemia on admis-
sion predictive for a marked inflammatory response and
lower leptinaemia had a “protective effect” (suppressed
CRP). Prolonged LOS in cervical HF patients was pre-
dicted by presence of CAD and in the trochanteric
Table 3 Significant correlations between laboratory
variables, age and length of hospital stay in older
patients with cervical and trochanteric hip fracture (HF)
(Pearson correlation coefficients)
Parameters Cervical HF Trochanteric HF
r P r P
Age - PTH 0.289 < 0.001 0.209 0.014
Age - eGFR -0.312 < 0.001 -0.238 0.009
Age - cTnI 0.262 0.002 0.222 0.012
Age - adiponectin 0.245 0.004 0.261 0.004
PTH - calcium -0.380 < 0.001 -0.180 0.036*
cTnI - eGFR -0.232 0.008 -0.332 < 0.001
PTH - eGFR -0.320 < 0.001 -0.386 < 0.001
Haemoglobin - eGFR 0.250 0.002 0.217 0.009
Haemoglobin - albumin 0.348 < 0.001 0.202 0.016
PTH - adiponectin 0.167 0.053* 0.268 0.004
PTH - leptin 0.235 0.005
PTH - LOS 0.200 0.017
LOS - phosphate 0.169 0.044*
Albumin - eGFR 0.244 0.002
PTH - phosphate 0.199 0.020*
PTH - cTnI 0.397 < 0.001
PTH - adiponectin 0.268 0.004
PTH - resistin 0.193 0.038*
Age - leptin - 0.301 < 0.001
Age - resistin 0.238 0.009
Leptin - adiponectin - 0.251 0.006
Leptin - haemoglobin 0.262 0.002
Leptin - CRP 0.226 0.008
Adiponectin - CRP - 0.205 0.026*
Resistin - eGFR - 0.301 < 0.001
Resistin - calcium 0.227 0.014
cTnI - haemoglobin - 0.195 0.028*
eGFR, estimated glomerular filtration rate; cTnI, cardiac troponin I; CRP, C-
reactive protein; LOS, length of stay. * Non-significant correlations when
Bonferroni and Sidak adjustments for multiplicity adopted.
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group by age ≥ 75 years and elevated PTH. In both
groups need of institutionalisation was strongly pre-
dicted by age ≥ 75 years and pre-existing dementia.
Hypovitaminosis D in subjects with cervical HF and sec-
ondary hyperparathyroidism in patients with trochan-
teric HF were also independent predictors of this
outcome. The independent predictors of in-hospital
death were male sex, elevated PTH and lower leptin
levels in patients with cervical HF, and secondary hyper-
parathyroidism in subjects with trochanteric HF.
Discussion
Our study shows that the socio-demographic, clinical
and routine laboratory profiles as well as the incidence
of poorer short-term outcomes in the two main HF
types are rather similar, but the risk factors for the
short-term outcomes are different, likely reflecting the
differences in the underlying mechanisms especially
PTH and adipocytokines dysregulation.
In our cohort of 761 unselected consecutive HF
patients there was no significant difference between the
two HF types in respect to gender, residential status,
chronic illness, ASA score, ambulating with an assistive
device, smoking and alcohol consumption. Our data on
demography, comorbidity burden and mortality in older
HF patients is comparable to that in previous published
studies [43] and consistent with observations that there
are no differences between the two HF groups in the
type and number of comorbidities and prefracture resi-
dence [15]. In our series, statistically significant differ-
ences between cervical and trochanteric HF groups were
mean age (in the latter group females were older than
males) and prevalence of Parkinson’s disease (higher in
the former group). The first observation is in line with
many [7,20,22,44] but not all [15] previous reports; the
cause of the second is unclear.
Comparison of a wide range of routine haematologic
and biochemical variables including renal, liver and
thyroid function tests showed that only mean haemoglo-
bin and albumin levels were associated with HF type,
being slightly lower in the trochanteric group.
Much recent attention has focussed on health effects
of factors with multiple physiological roles such as vita-
min D, PTH and adipocytokines, peptides secreted
mainly by white adipose tissue. However the role of ana-
tomical location of HF in these relationships and the
potential implications for clinical practice are largely not
known.
In accordance with previous reports [45-47], we found
a very high prevalence of hypovitaminosis D in both
types of HF (77.8% in cervical and 82.1% in trochan-
teric) and secondary hyperparathyroidism in 30.2% and
41.3% respectively. Trochanteric compared to the cervi-
cal HF patients, despite similarly low mean 25(OH) D
Table 4 Independent predictors of short-term outcomes in older patients with cervical and trochanteric hip fracture
(HF)
Outcome Predictor Cervical HF Trochanteric HF
OR 95% CI P OR 95% CI P
Postoperative myocardial injury (cTnI > 0.06 μg/L) CAD 5.9 1.5-22.3 0.010
Dementia 3.3 1.3-7.9 0.010
Smoker 18.3 2.2-153.8 0.007
eGFR < 60 ml/min 3.3 1.4-8.0 0.008
PTH > 6.8 pmol/L 3.7 1.1-12.0 0.031
Leptin < 11.35 ng/ml 4.8 1.1-20.0 0.039
Marked inflammatory response (CRP > 100 mg/L) Hb < 120 g/L 6.8 1.6-28.8 0.009
Leptin < 11.35 ng/ml 0.5 0.32-0.94 0.034
LOS ≥ 20 days Age > 75 years 5.8 1.1-30.9 0.040
CAD 4.5 1.5-13.3 0.006
PTH > 6.8 pmol/L 3.5 1.1-10.9 0.029
Long-term RCF need Age > 75 years 14.0 1.01-195.1 0.049 10.7 1.6-73.4 0.016
Dementia 40.0 2.8-571.4 0.007 12.9 2.8-59.5 0.001
25(OH)D < 50 nmol/L 10.3 1.8-57.9 0.008
PTH > 6.8 pmol/L 7.0 1.2-43.1 0.035
In-hospital death Sex (male) 6.9 1.04-45.6 0.045
PTH > 6.8 pmol/L 28.4 2.6-306.0 0.006 7.3 2.1-31.9 0.003
Leptin < 11.35 ng/ml 14.3 1.4-99.9 0.025
Multivariate logistic regression analyses included all variables with P ≤ 0.15 on univariate analyses.
CAD, coronary artery disease; cTnI, cardiac troponin I; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; RCF, residential care facility.
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concentrations, had a 36.5% increase in mean serum
PTH level. These results are in agreement with those
reported by many other investigators, except Dretakis et
al [48] who among 53 older women with HF found that
25(OH)D levels were significantly lower in patients with
trochanteric compared to those with cervical HF, while
the PTH levels were simular. Another important differ-
ence between cervical and trochanteric HF groups in
our study is that in the former mean levels of adiponec-
tin and resistin were significantly higher than in the
latter.
We found no noteworthy differences between the two
HF types in terms of postoperative inflammatory
response (assessed by CRP evaluation) and myocardial
injury (evaluated by cTnI rise), nor in LOS, percentage
of subjects being newly discharged to long-term RCF
and in-hospital mortality rate. Data on the associations
between HF type and short-term outcomes are sparse
and inconsistent, though some previous reports found a
longer LOS [29,30] and higher mortality in trochanteric
HF [7,15,17,34]. Our results are in line with observations
that HF type is not an independent prognostic factor
[43,49] and is not associated with LOS [15]. Our find-
ings coupled with the literature data show that prog-
nosis of short-term outcomes based exclusively on HF
type is unhelpful.
The major and novel finding in this study is that the
risk factor profiles for certain outcomes differ by the HF
type. Comparison of outcomes in cervical and trochan-
teric HFs in principle cannot provide evidence for or
against the hypotheses that two fracture types share
common pathophysiology. Statistically similar incidence
of certain outcomes can arise from different factors, and
similar abnormalities may contribute to different out-
comes. Our data on Pearson correlation coefficients
between selected laboratory parameters, including 25
(OH)D, PTH, adipocytokines, age and LOS, documented
similarities and differences between the two HF types.
In total, there were 10 significant correlations common
for both HF types, 4 statistically significant relationships
observed only in cervical HF and 13 correlations were
seen only in trochanteric HF (after Bonferroni and
Sedak adjustments for multiplicity 8, 3 and 8 respec-
tively). Although the full discussion of the reason for
these differences is beyond the scope of this paper, the
present data suggest that the complex relationships
between PTH, adipocytokines, renal function and age in
older HF patients are site-specific.
Our multivariate analyses of a variety of laboratory
parameters as continuous variables revealed that post-
operative myocardial injury in patients with cervical HF
was independently predicted only by a decrease in
eGFR, while in patients with trochanteric HF also by
increased PTH levels and decrease in serum 25(OH) D.
Lower leptin levels were independently associated with
in-hospital death in the former group and with need of
institutionalization in the latter group. In patients with
cervical HF, higher PTH levels were predictive of pro-
longed LOS and in-hospital death, and lower 25(OH) D
indicated a marked inflammatory response, whereas in
patients with trochanteric HF, PTH was associated with
in-hospital mortality but none of the laboratory para-
meters predicted an inflammatory response or LOS.
Increasing age as a continuous variable was a significant
independent predictor of post-operative myocardial
injury and need of institutionalization in both groups
and predicted LOS and inflammatory response (nega-
tively) in patients with trochanteric HF.
To provide practicing physicians with useful prognos-
tic indicators regarding short-term HF outcomes we
performed multivariate analyses of clinical and labora-
tory characteristics as categorical variables. These
showed that in models based on HF type, clinical char-
acteristics on admission were predictive of certain unfa-
vourable short-term outcomes indicating that outcomes
depend in large part on the preoperative conditions and
the risks are HF-site specific. Not surprisingly advanced
age (> 75 years), dementia and history of CAD were the
most often and easily ascertained clinical predictors of
poor outcomes but differ by HF type. Our final models
included both clinical and laboratory variables. Although
adding laboratory parameters often resulted in a rela-
tively small improvement of overall prediction, the
laboratory characteristics yielded useful pathophysiologi-
cal information concerning certain HF outcomes and
potential targets for preventive and therapeutic
interventions.
Among a variety of laboratory parameters examined,
independent associations with certain outcomes
demonstrated only five analysed as categorical variables
(elevated PTH, low leptin, 25(OH)D, eGFR and haemo-
globin) with PTH and leptin predicting 4 and 3 out-
comes, respectively (Figure 1). Previously we have
shown that elevated PTH is a strong independent pre-
dictor of poor outcomes in older HF patients [50].
This study importantly adds that the strong indepen-
dent associations of PTH with certain adverse events
are HF-type specific. Secondary hyperparathyroidism
predicted in-hospital death in both HF types, but was
associated with post-operative myocardial injury, pro-
longed LOS and need in a long-term RCF only in
patients with trochanteric HF. Similarly, in a prior
study we found that lower leptin levels indicate poor
outcome, specifically myocardial injury and in-hospital
death [51]. Our results are in line with a recently pub-
lished prospective study which found that low leptin
was associated with increased cardiovascular events
and mortality in patients with stable CAD [52],
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although others reported contrary observations [53,54].
Patient-related factors (HF type and related mechan-
isms in our case) are a possible explanation for this
discrepancy. The current study found that lower serum
leptin is an independent predictor of the myocardial
injury in patients with trochanteric HF and in-hospital
death in patients with cervical HF.
Our results are in line with the growing evidence that
bone mineral density (BMD), mechanical, geometrical
and material characteristics of the proximal femur as
well as clinical risk factors significantly differ in patients
with cervical and trochanteric HF [7,9,15,16,55-57]. Our
observations are also supported by the fact that PTH
[58-61], leptin and other adipocytokines [62,63]; have
Outcomes in             Independent         Outcomes in 
patients with              risk factors          patients with 
 cervical HF            trochanteric HF 
Age>75 years 
Male sex 
CAD 
Dementia 
Smoker 
PTH>6.8pmol/L 
Leptin<11.35 ng/ml 
eGFR <60ml/min.1.73m2
25(OH)D<50nmol/L
Haemoglobin<120g/L 
LOS 20 days
Post-operative 
myocardial 
injury 
Marked
inflammatory 
response 
Need of long-
term RCF
In-hospital
death 
Post-operative 
myocardial injury 
(cTnI>0.06μg/L) 
Marked 
inflammatory 
response 
(CRP>100mg/L) 
Need of long-
term RCF 
In-hospital
death
LOS 20 days
-
Figure 1 Independent risk factors for short-term outcomes in older patients with hip fracture by fracture site. CAD, coronary artery
disease; LOS, length of hospital stay; RCF, residential care facility; cTnI, cardiac troponin I; CRP, C-reactive protein.
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differing effects on cortical and trabecular bone, includ-
ing the hip. Furthermore, recent studies indicate com-
mon aetiologies and mechanisms for certain medical
illnesses, bone loss and osteoporotic fractures [64,65],
and PTH and adipocytokines are important factors act-
ing in bone, cardiovascular, metabolic and kidney dis-
eases [62]. Taken together, these data suggest important
differences in metabolic interrelationships and pathoge-
netic pathways which may simultaneously contribute to
HF type, comorbidities and certain outcomes. Whereas
additional work will be needed to identify the optimal
variables for predicting HF outcomes, our study con-
firms that the risk factors should be assessed separately
for cervical and trochanteric HFs.
Our study based on evaluation of a relatively large
number of unselected consecutive and prospectively
observed older patients with HF, in whom a wide variety
of clinical and laboratory parameters were determined, is
the first systematically seeking to clarify the risks of poor
short-term outcomes by HF type. Despite this strength,
several limitations of the study require consideration.
First, because of its cross-sectioned design no inference
can be made on causal relationships. Second, no categori-
zation of the causes of death, rise of cTnI and CRP was
undertaken and subgroups were not analysed because of
the limited number of cases. As each of these outcomes
has multifactorial causes and heterogenetic pathophysiol-
ogy, additional or different risk factors may be found in
future studies. Third, all laboratory parameters were
measured on admission and thereafter, therefore the pos-
sibility that fracture-related stress may affect some meta-
bolic parameters could not be excluded. However,
adjustment for urinary cortisol levels normalised for crea-
tinine (not shown) did not modify any of the described
associations. We also acknowledge that multiple compar-
isons may potentiate the significance of multicollinearity
phenomena in multivariate regression analysis. However,
the variance inflation factor in all prediction models pre-
sented in Table 4 was less than 1.7, indicating that the
amount of multicollinearity was not significant. Lastly,
the results of the study may not be applicable to all
elderly HF patients due to the very high prevalence of
white Caucasians in our cohort.
Conclusions
Clinical characteristics and incidence of poorer short-
term outcomes in the two main HF types are rather
similar but risk factors for certain outcomes are site-spe-
cific reflecting differences in underlying mechanisms.
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